These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25795947)

  • 1. Whey and soy protein supplements changes body composition in patients with Crohn's disease undergoing azathioprine and anti-TNF-alpha therapy.
    Machado JF; Oya V; Coy CS; Morcillo AM; Severino SD; Wu C; Sgarbieri VC; Vilela MM
    Nutr Hosp; 2015 Apr; 31(4):1603-10. PubMed ID: 25795947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional supplementation assessment with whey proteins and TGF-β in patients with Crohn's disease.
    Davanço T; Oya V; Saddy Rodrigues Coy C; Franco Leal R; de L Setsuko Ayrizono M; Sgarbieri VC; dos Santos Vilela MM; Lomazi EA
    Nutr Hosp; 2012; 27(4):1286-92. PubMed ID: 23165575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whey protein preloads are more beneficial than soy protein preloads in regulating appetite, calorie intake, anthropometry, and body composition of overweight and obese men.
    Tahavorgar A; Vafa M; Shidfar F; Gohari M; Heydari I
    Nutr Res; 2014 Oct; 34(10):856-61. PubMed ID: 25277886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of anti-TNFα Induction Therapy on the Nutritional Status and Dietary Intake in Inflammatory Bowel Disease.
    Csontos ÁA; Molnár A; Piri Z; Katona B; Dakó S; Pálfi E; Miheller P
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):49-56. PubMed ID: 27014753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein blend ingestion before allogeneic stem cell transplantation improves protein-energy malnutrition in patients with leukemia.
    Ren G; Zhang J; Li M; Yi S; Xie J; Zhang H; Wang J
    Nutr Res; 2017 Oct; 46():68-77. PubMed ID: 28964569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BODY COMPOSITION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS.
    Back IR; Marcon SS; Gaino NM; Vulcano DSB; Dorna MS; Sassaki LY
    Arq Gastroenterol; 2017; 54(2):109-114. PubMed ID: 28198913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.
    Diamanti A; Basso MS; Gambarara M; Papadatou B; Bracci F; Noto C; Castro M
    Int J Colorectal Dis; 2009 Jan; 24(1):19-25. PubMed ID: 18797887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Nutritional Impact of a Semi-Elemental Hydrolyzed Whey Protein Diet in Patients with Active Crohn's Disease: A Prospective Observational Study.
    Ferreiro B; Llopis-Salinero S; Lardies B; Granados-Colomina C; Milà-Villarroel R
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradialytic protein supplementation reduces inflammation and improves physical function in maintenance hemodialysis patients.
    Tomayko EJ; Kistler BM; Fitschen PJ; Wilund KR
    J Ren Nutr; 2015 May; 25(3):276-83. PubMed ID: 25455421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.
    Cosnes J; Bourrier A; Laharie D; Nahon S; Bouhnik Y; Carbonnel F; Allez M; Dupas JL; Reimund JM; Savoye G; Jouet P; Moreau J; Mary JY; Colombel JF;
    Gastroenterology; 2013 Oct; 145(4):758-65.e2; quiz e14-5. PubMed ID: 23644079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn's disease.
    Gupta N; Lustig RH; Chao C; Vittinghoff E; Andrews H; Leu CS
    World J Gastroenterol; 2018 May; 24(18):2036-2046. PubMed ID: 29760546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.
    Panés J; López-Sanromán A; Bermejo F; García-Sánchez V; Esteve M; Torres Y; Domènech E; Piqueras M; Gomez-García M; Gutiérrez A; Taxonera C; Sans M;
    Gastroenterology; 2013 Oct; 145(4):766-74.e1. PubMed ID: 23770132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of biological therapy on body composition of patients with Chron's disease.
    Santos JCD; Malaguti C; Lucca FA; Cabalzar AL; Ribeiro TCDR; Gaburri PD; Chebli LA; Chebli JMF
    Rev Assoc Med Bras (1992); 2017 May; 63(5):407-413. PubMed ID: 28724037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of nutrition status in Crohn's disease patients receiving infliximab therapy.
    Wiese D; Lashner B; Seidner D
    Nutr Clin Pract; 2008; 23(5):551-6. PubMed ID: 18849561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease.
    Peyrin-Biroulet L; Oussalah A; Williet N; Pillot C; Bresler L; Bigard MA
    Gut; 2011 Jul; 60(7):930-6. PubMed ID: 21228429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of soy- and whey protein-isolate supplemented diet on the redox parameters of trained mice.
    Elia D; Stadler K; Horváth V; Jakus J
    Eur J Nutr; 2006 Aug; 45(5):259-66. PubMed ID: 16575496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy.
    Emerenziani S; Biancone L; Guarino MPL; Balestrieri P; Stasi E; Ribolsi M; Rescio MP; Altomare A; Cocca S; Pallone F; Cicala M
    Dig Liver Dis; 2017 May; 49(5):495-499. PubMed ID: 28096060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
    Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
    Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nutritional supplementation for HIV patients starting antiretroviral treatment: randomised controlled trial in Ethiopia.
    Olsen MF; Abdissa A; Kæstel P; Tesfaye M; Yilma D; Girma T; Wells JC; Ritz C; Mølgaard C; Michaelsen KF; Zerfu D; Brage S; Andersen AB; Friis H
    BMJ; 2014 May; 348():g3187. PubMed ID: 25134117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.